| Display title | Medicine:Tumor-infiltrating lymphocytes |
| Default sort key | Tumor-infiltrating lymphocytes |
| Page length (in bytes) | 24,577 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 862431 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Len Stevenson |
| Date of page creation | 01:48, 5 February 2024 |
| Latest editor | imported>Len Stevenson |
| Date of latest edit | 01:48, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Tumor-infiltrating lymphocytes (TIL) are white blood cells that have left the bloodstream and migrated towards a tumor. They include T cells and B cells and are part of the larger category of ‘tumor-infiltrating immune cells’ which consist of both mononuclear and polymorphonuclear immune cells, (i.e... |
